Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder
The findings of this study indicate that pharmacogenomics testing positively influences treatment adherence and may decrease the need to switch medications among patients with depression.
Authors
- Yuhang Yan
- Chaoli Chen (ORCID: https://orcid.org/0009-0009-3250-1145)
- Mengqiang Zhao (ORCID: https://orcid.org/0000-0001-6584-4552)
- Yang Lun
- Ruxing Li
- Shijie Su (ORCID: https://orcid.org/0000-0003-2784-9832)
- Yuanyuan Zhao (ORCID: https://orcid.org/0000-0001-6743-3722)
- Chunhua Zhou (ORCID: https://orcid.org/0000-0003-1543-9000)
- Xiaoying Geng
- Ziyu Liu (ORCID: https://orcid.org/0000-0002-2888-3066)
- Yan Liu (ORCID: https://orcid.org/0000-0002-9904-4438)
- Jing Yu (ORCID: https://orcid.org/0000-0001-5015-7952)
- Liang Duan
- Jinxiao Li (ORCID: https://orcid.org/0000-0001-9178-2279)
- Xiaochuan Zhao (ORCID: https://orcid.org/0000-0001-5840-3601)
- Feng‐Rong An
- Ran Fu
- Jiaqi Wang (ORCID: https://orcid.org/0009-0008-7293-3156)
Institutions
- Hebei Medical University (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-11-29
- DOI
- https://doi.org/10.3389/fphar.2024.1501381
- Citations
- 1
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39